Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating expenses:    
General and administrative $ 1,173,258 $ 340,172
Research and development 1,279,037 137,104
Total operating expenses 2,452,295 477,276
NET LOSS $ (2,452,295) $ (477,276)
Net loss per share of common shares, basic and diluted (in Dollars per share) $ (0.24) $ (0.24)
Weighted-average number of common shares outstanding, basic and diluted (in Shares) 10,074,623 2,020,966